Biologic sex is not the only difference between men and women: data from the Doravirine phase 2/3 clinical trials

被引：0
|
作者：
Walmsley, S. [1 ]
Squires, K. [2 ]
Martin, E. [2 ]
Xu, Z. J. [2 ]
Hwang, C. [2 ]
Sklar, P. [2 ]
Sordet, F. [2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Merck & Co Inc, Kenilworth, NJ USA
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PE3/9
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] Clinical data from Phase 3 trials in Pramlintide
    不详
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 1999, 15 (02) : 157 - 157
  • [2] Characterization of doravirine-selected resistance patterns from participants in treatment-naive Phase 3 clinical trials
    Lai, M. -T.
    Xu, M.
    Ngo, W.
    Feng, M.
    Hazuda, D.
    Hanna, G.
    Kumar, S.
    Xu, X.
    Martin, E.
    Hwang, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 137 - 138
  • [3] Outcomes of 19 unplanned pregnancies in women participating in phase 2 or 3 eliglustat clinical trials and 18 pregnancies in the partners of men who participated in these trials
    Balwani, Manisha
    Lukina, Elena
    Belmatoug, Nadia
    Watman, Nora
    Hughes, Derralynn
    Gaemers, Sebastiaan J. M.
    Kim, Yestle
    Foster, Mererdith
    Peterschmitt, M. Judith
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S27 - S28
  • [4] Increasing difference in survival between women and men from 2001 to 2010: Data from the Danish oxygen register
    Ringbaek, Thomas
    Brinkved, Christina
    Lange, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials
    Goldberg, Anne C.
    Banachb, Maciej
    Catapano, Alberico L.
    Duell, P. Barton
    Leiter, Lawrence A.
    Hanselman, Jeffrey C.
    Leif, Lei
    Mancini, John
    ATHEROSCLEROSIS, 2023, 384
  • [6] Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials
    Tambiah, Jeyanesh
    Kennedy, Sarah
    Swearingen, Christopher
    Mcalindon, Timothy
    Yazici, Yusuf
    RHEUMATOLOGY, 2024,
  • [7] IXABEPILONE-ASSOCIATED PERIPHERAL NEUROPATHY: RETROSPECTIVE REVIEW OF DATA FROM PHASE 2 AND 3 CLINICAL TRIALS
    Donovan, Diana
    Roche, Henri
    Hortobagyi, Gabriel
    Sparano, Joseph
    Mukhopadhyay, Pralay
    Vahdat, Linda
    ONCOLOGY NURSING FORUM, 2011, 38 (02) : E121 - E121
  • [8] Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials
    Woyach, Jennifer A.
    BLOOD, 2019, 134 (21) : 1796 - 1801
  • [9] Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials
    Woyach, Jennifer A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 476 - 481
  • [10] Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough
    V. Dicpinigaitis, Peter
    Birring, Surinder S.
    Blaiss, Michael
    McGarvey, Lorcan P.
    Morice, Alyn H.
    Pavord, Ian D.
    Satia, Imran
    Smith, Jaclyn A.
    La Rosa, Carmen
    Li, Qing
    Nguyen, Allison Martin
    Schelfhout, Jonathan
    Tzontcheva, Anjela
    Muccino, David
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (01) : 60 - 66
12345